In this age and time where cancer is single handily towing apart most families and patients, Mikhail Blagosklonny is by far a blessing to the society. To those who do not know Mikhail Blagosklonny, he is an oncologist with a special interest in cancer treatment, a professor, and an auditor to an online publication, OncoTarget. Concisely, Mikhail’s life is all about Oncology.
According to Mikhail Blagosklonny, aging is the prime causative factor to most chronic diseases in the world today including Cancer. For a person of Mikhail’s qualification, there is no doubt in his findings. Mikhail Blagosklonny is a seasoned scholar and researcher in the science field. He attained his MD in Internal Medicine from the First Pavlov State Medical University and a Ph.D. from the same institution specializing in Experimental Medicine and Cardiology. Upon graduation, he was hired by New York Medical College to work as an Associate Professor in 2002. His love or research and experimental sciences saw him join Ordway Research Institute as a senior scientist. It is here that Mikhail Blagosklonny did most of his experimental research on the effect of aging treatment on the cure and care of cancer patient. After working for the institution for some time, Mikhail decided to make his big career move in 2009 when joined Roswell Park Cancer Institute as a full board Professor of Oncology.
To understand Mikhail Blagosklonny and his contributions towards cancer treatment, you first need to comprehend his area of research. Mikhail’s concentrates on signal transduction, cellular senescence, cell cycle, new anticancer strategies, and anticancer therapeutics. One of Mikhail famous hypothesis includes the use of rapamycin as a possible drug in preventing aging and extending the human life. The drug that is commonly used in cancer treatment and Mikhail believes that if given in the right doses, it can prevent a couple of body complication including nephropathy and cell failure.
Mikhail Blagosklonny is the epitome of hope for cancer patients. According to his departmental head and Impact Journals, Mikhail approach to cancer treatment by focusing on preventing the aging process is quite insightful. Mikhail’s approaches not only help slow down the effect of cancer in the body and better still cure them, but they also contribute to ensuring that the body organs such a kidneys remain intact. View his LinkedIn profile
The other way Mikhail Blagosklonny is affecting science and specifically research all over the word is through the online publication he and a colleague at Roswell Park Cancer Institute are running. OncoTarget is the name of the online publication that seeks to impact readers all over the world with a deep understanding of scientific facts. Additionally, the publication also offers upcoming scholars and researchers a platform on to showcase their findings to the world. The success of the weekly publication that was specifically targeting oncology has seen Mikhail include other science subjects on boards.
Seeing Cancer through the eyes of Mikhail is optimism. Regardless of the state of affairs with the disease today, one day it will be a thing of the past thanks to the contributions of researcher and scholars such a Mikhail.